Nominations for the plc awards 2021 are now open! See the 2021 award categories and criteria here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8,191.00
Bid: 8,140.00
Ask: 8,143.00
Change: -40.00 (-0.49%)
Spread: 3.00 (0.04%)
Open: 8,250.00
High: 8,261.00
Low: 8,098.00
Prev. Close: 8,191.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE 2-Oxford University says research not affected after media reports of COVID lab hack

Thu, 25th Feb 2021 20:31

(Recasts with Oxford statement, adds background)

Feb 25 (Reuters) - Oxford University said on Thursday it was
investigating a cyber attack but that research was unaffected,
following media reports that one of its biology laboratories
researching COVID-19 had been hacked.

The breach took place in mid-February and occurred at the
Division of Structural Biology, known as Strubi, which has been
carrying out research into COVID-19, according to Forbes and The
Telegraph.

Strubi is distinct from the Jenner Institute, which develops
the Oxford COVID-19 vaccine in partnership with AstraZeneca
.

Oxford University confirmed there had been a hack in an
emailed statement to Reuters and said it was investigating.

"We have identified and contained the problem and are now
investigating further. There has been no impact on any clinical
research, as this is not conducted in the affected area," an
Oxford spokesman said, adding that the university was working
with the National Cyber Security Centre (NCSC) on the incident.

It did not name the facility affected.

The Telegraph newspaper quoted security sources as saying it
was unclear who was behind the attack and that they could not
rule out a hostile foreign state.

NCSC, the cyber security arm of spy agency GCHQ, did not
immediately respond to a request for comment.

Digital espionage targeting health bodies, vaccine
scientists and drugmakers has surged during the COVID-19
pandemic as state-backed hacking groups scramble to secure the
latest research and information about the outbreak.

In December, U.S. drugmaker Pfizer Inc and its
German partner BioNTech SE disclosed that documents
related to development of their COVID-19 vaccine had been
"unlawfully accessed" in a cyberattack on Europe's medicines
regulator.
(Reporting by Bhargav Acharya and Derek Francis in Bengaluru;
Editing by Catherine Evans and Rosalba O'Brien)

More News

Two Hutchmed drugs included in China's 2022 reimbursement list

(Sharecast News) - Hutchmed China announced on Friday that, following negotiations with the China National Healthcare Security Administration (NHSA), from 1 January the updated National Reimbursement Drug List (NRDL) will continue to include 'Elunate', or fruquintinib, and would now include 'Sulanda', or surufatinib.

3 Dec 21 13:23

UPDATE 1-UK study finds mRNA COVID-19 vaccines provide biggest booster impact

* Data behind UK booster decision published* Pfizer and Moderna give large antibody, T-cell boosts* Broad T-cell responses give hope of variant protection (Adds reaction, additional study, TV media marker)By Alistair SmoutLONDON, Dec 3 (Reuters) - C...

3 Dec 21 11:58

UK study finds mRNA COVID-19 vaccines provide biggest booster impact

* Data behind UK booster decision published* Pfizer and Moderna give large antibody, T-cell boosts* Broad T-cell responses give hope of variant protectionBy Alistair SmoutLONDON, Dec 2 (Reuters) - COVID-19 vaccines made by Pfizer and Moderna that us...

2 Dec 21 23:30

UPDATE 3-India reports first Omicron cases, no plan to authorize boosters

* Two cases detected in Karnataka showing mild symptoms* Officials say priority is to fully vaccinate adults first (Adds details on vaccines)BENGALURU, Dec 2 (Reuters) - India reported its first two cases of the Omicron coronavirus variant on Thurs...

2 Dec 21 11:18

UPDATE 4-India reports first Omicron cases, no plan to authorise boosters

* Two cases detected in Karnataka showing mild symptoms* Officials say priority is to fully vaccinate adults first (Adds details of the patients in paragraphs 3-6)By Anuron Kumar Mitra and Chandini MonnappaBENGALURU, Dec 2 (Reuters) - India reported...

2 Dec 21 11:18

UPDATE 2-EU regulator begins real-time review of Valneva's COVID-19 shot

(adds Valneva comment on Omicron variant)Dec 2 (Reuters) - The European Union's drug regulator said on Thursday it had started a rolling review of the protein-based COVID-19 vaccine from French biotech firm Valneva, weeks after the EU signed a dea...

2 Dec 21 10:54

CORRECTED-UPDATE 2-EU regulator begins real-time review of Valneva's COVID-19 shot

(Corrects description to inactivated virus, in paragraph 1)Dec 2 (Reuters) - The European Union's drug regulator said on Thursday it had started a rolling review of the inactivated-virus COVID-19 vaccine from French biotech firm Valneva, weeks aft...

2 Dec 21 10:54

Omicron cases outside South Africa no deadlier, Australian official says

(Sharecast News) - On current evidence, the Omicron variant of Covid-19 did not yet appear to be any deadlier than previous ones, Australian health officials said.

2 Dec 21 08:40

UPDATE 2-GSK says tests indicate antibody drug works against Omicron

* Sotrovimab, developed with Vir, tested in lab and on hamsters* Key Omicron mutations did not elude drug activity in study* Tests continuing on further mutations (Adds background on rival drugs)By Ludwig BurgerDec 2 (Reuters) - Laboratory analysis...

2 Dec 21 07:56

UPDATE 3-GSK says tests indicate antibody drug works against Omicron

* Sotrovimab, developed with Vir, tested in lab and on hamsters* Key Omicron mutations did not elude drug activity in study* Tests continuing on further mutations (Adds methods, chief scientist's comment)By Ludwig BurgerDec 2 (Reuters) - Laboratory...

2 Dec 21 07:56

UK agrees deals for 114 million more Moderna and Pfizer COVID-19 doses

By Michael HoldenLONDON, Dec 1 (Reuters) - Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the n...

1 Dec 21 22:30

India's SII promises 40 mln more AstraZeneca doses to COVAX this year

By Krishna N. DasNEW DELHI, Dec 1 (Reuters) - Serum Institute of India (SII) has pledged to supply about 40 million doses of the AstraZeneca COVID-19 shot to the global vaccine-distribution network COVAX by year-end after resuming exports last wee...

1 Dec 21 16:11

REUTERS NEXT-UK's Bingham expects Omicron vaccine impact to be known in a week

* Says UK can test shots against variants quickly* Says cancelled UK Valneva contact was for variantsLONDON, Dec 1 (Reuters) - Kate Bingham, the former head of the UK's COVID-19 Vaccine Taskforce who secured millions of doses for the country, said ...

1 Dec 21 14:57

All confirmed Omicron cases in EU thus far are asymptomatic or have shown mild symptoms

(Sharecast News) - All confirmed cases of the Omicron variant of concern detected thus far in the European Union had thus far had been either asymptomatic or shown "mild" symptoms, the bloc's pandemic watchdog said.

30 Nov 21 21:49

WRAPUP 10-Officials offer vaccine reassurance, WHO advises against travel bans

(Adds WHO comment)* Drugmaker CEO warns of 'material drop' in effectiveness* Markets fall on fears of prolonged COVID-19 pandemic* Partly recover on more upbeat comments from EU officials* Time needed to know if vaccines work against Omicron* Japan r...

30 Nov 21 20:10

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.